MORRISON LISA

PrivateCIK: 1635111
Location

HELLERUP, G7

MORRISON LISA enters ASCENDIS PHARMA A/S with 1.57K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderMORRISON LISACIK 1635111
IssuerASCENDIS PHARMA A/SCIK 1612042
Director
Since Mar 2026
1.57K
Baseline shares
100% direct
1.57K
Direct ownership
1 position
45.45K
Derivative underlying
9 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Ordinary Shares

Direct
Shares owned1.57K
Total
1.57K direct1.57K
Derivative Holdings9

Restricted Stock Units

Direct
Underlying security
Ordinary Shares

Underlying shares

1.93K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

5K

Shares owned

N/A

Exercise price

37.18

Expiration

Exercise window

Restricted Stock Units

Direct
Underlying security
Ordinary Shares

Underlying shares

2.07K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

13K

Shares owned

N/A

Exercise price

62.17

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

6.42K

Shares owned

N/A

Exercise price

176.28

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

7.50K

Shares owned

N/A

Exercise price

108

Expiration

Exercise window

Restricted Stock Units

Direct
Underlying security
Ordinary Shares

Underlying shares

1.37K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

5.11K

Shares owned

N/A

Exercise price

22.76

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

3.05K

Shares owned

N/A

Exercise price

139.65

Expiration

Exercise window

Total

Underlying

45.45K

Owned

0.00

MORRISON LISA — Initial Ownership Disclosure (Form 3) Filed Mar 18, 2026 | Finecho